103 related articles for article (PubMed ID: 8958191)
1. Effects of cilazapril on exercise tolerance in the chronic phase of acute myocardial infarction.
Tanabe K; Suzuki N; Osada N; Yamamoto A; Nakayama M; Yokoyama Y; Sakakibara M; Itoh H; Murayama M; Yamada S; Yamasaki H
Jpn Circ J; 1996 Nov; 60(11):831-40. PubMed ID: 8958191
[TBL] [Abstract][Full Text] [Related]
2. [Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction].
Fujiwara M; Asakuma S; Nakamura T; Nakamura K; Iwasaki T
J Cardiol; 1995 Nov; 26(5):287-92. PubMed ID: 8523261
[TBL] [Abstract][Full Text] [Related]
3. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
4. [Effect of angiotensin converting enzyme inhibitor lisinopril on sympathetic heart rate response during exercise in the early phase of acute myocardial infarction].
Akashi Y; Tanabe K; Osada N; Samejima H; Seki A; Yokoyama Y; Nakayama M; Suzuki N; Oomiya K; Itoh H; Miyake F; Murayama M
J Cardiol; 2000 Oct; 36(4):221-9. PubMed ID: 11079227
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
Bernasconi M; Marone C; Beretta-Piccoli C; Lepori G; Shaw S; Weidmann P
Am J Hypertens; 1991 Apr; 4(4 Pt 1):348-55. PubMed ID: 1829371
[TBL] [Abstract][Full Text] [Related]
6. The effect of acute ACE inhibition on atrial natriuretic peptide.
Doorenbos CJ; van Brummelen P
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):243S-247S. PubMed ID: 2527537
[TBL] [Abstract][Full Text] [Related]
7. Effects of candesartan and cilazapril on rats with myocardial infarction assessed by echocardiography.
Yoshiyama M; Takeuchi K; Omura T; Kim S; Yamagishi H; Toda I; Teragaki M; Akioka K; Iwao H; Yoshikawa J
Hypertension; 1999 Apr; 33(4):961-8. PubMed ID: 10205231
[TBL] [Abstract][Full Text] [Related]
8. Effect of cilazapril on exercise tolerance in congestive heart failure.
Corder CN; Rubler S; Deere LF; Puls A; Peguero-Rivera A; Nagarajan R; Harwood W
Pharmacology; 1993; 46(3):148-54. PubMed ID: 8441761
[TBL] [Abstract][Full Text] [Related]
9. Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.
Tylicki L; Renke M; Rutkowski P; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2008; 42(4):381-8. PubMed ID: 19230172
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of cilazapril, carvedilol and their combination in preventing from left ventricular remodelling after acute myocardial infarction in rats.
Yang Y; Tang Y; Ruan Y; Li Y; Zhou Y; Gao R; Chen J; Chen Z
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):31-5. PubMed ID: 11984745
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients.
Fioretto P; Frigato F; Velussi M; Riva F; Muollo B; Carraro A; Brocco E; Cipollina MR; Abaterusso C; Trevisan M
Am J Hypertens; 1992 Nov; 5(11):837-46. PubMed ID: 1457087
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
[TBL] [Abstract][Full Text] [Related]
13. [Changes in plasma level of brain natriuretic peptide during exercise in recovery phase of myocardial infarction and the clinical significance].
Yokoyama Y; Tanabe K; Yamada S; Itoh H
J Cardiol; 1996 Mar; 27(3):121-31. PubMed ID: 8865684
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the pharmacokinetics and pharmacodynamics of cilazapril between Chinese and Caucasian healthy, normotensive volunteers.
Anderson PJ; Critchley JA; Tomlinson B
Eur J Clin Pharmacol; 1996; 50(1-2):57-62. PubMed ID: 8739812
[TBL] [Abstract][Full Text] [Related]
15. Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.
Belz GG; Essig J; Kleinbloesem CH; Hoogkamer JF; Wiegand UW; Wellstein A
Br J Clin Pharmacol; 1988 Nov; 26(5):547-56. PubMed ID: 2974715
[TBL] [Abstract][Full Text] [Related]
16. The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure.
White WB; McCabe EJ; Hager WD; Schulman P
Clin Pharmacol Ther; 1988 Aug; 44(2):173-8. PubMed ID: 2969315
[TBL] [Abstract][Full Text] [Related]
17. The effects of antihypertensive medications on the physiological response to maximal exercise testing.
Derman WE; Sims R; Noakes TD
J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S122-7. PubMed ID: 1381788
[TBL] [Abstract][Full Text] [Related]
18. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
Kleinbloesem CH; Erb K; Essig J; Breithaupt K; Belz GG
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
[TBL] [Abstract][Full Text] [Related]
19. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure.
Kinugawa T; Ogino K; Kitamura H; Saitoh M; Omodani H; Osaki S; Hisatome I; Miyakoda H
Am J Med Sci; 1996 Sep; 312(3):110-7. PubMed ID: 8783676
[TBL] [Abstract][Full Text] [Related]
20. Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.
Burnier M; Mooser V; Nussberger J; Waeber B; Brunner HR
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):189S-197S. PubMed ID: 2527532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
